Adamax

Adamax is an adamantane-modified Semax analog studied for nootropic and neuroprotective effects with potentially improved stability and blood-brain barrier penetration.

Profile · 01

Overview

Adamax is an adamantane-modified analog of Semax studied for nootropic, neuroprotective, and mood-support applications. The adamantane modification is used to explain improved lipophilicity, enzymatic stability, and blood-brain barrier penetration compared with standard Semax. It is not FDA-approved for any indication.

Most published support for Adamax remains preclinical or mechanism-based, so this page should be read as an educational research summary rather than a clinically validated human protocol. The source material describes a once-daily subcutaneous titration using a practical dilution for insulin-syringe measurements.

At a Glance

Goal
Support cognitive function, neuroprotection, and mood resilience through Semax-class neurotrophic signaling
Categories
NootropicNeuroprotectionCognitive EnhancementMood Support
Synergistic
Selank · Semax · Dihexa · GHK-Cu
Profile · 02

Protocol

Suggested daily titration approach starting low and increasing every two weeks.

Reconstitute
Add 3.0 mL bacteriostatic water to a 10 mg vial for about 3.33 mg/mL concentration
Typical daily range
300-1,000 mcg once daily
Start
300 mcg daily for Weeks 1-2
Target
750-1,000 mcg daily by Weeks 5-8+
Frequency
Once per day (subcutaneous)
Cycle Length
8-12 weeks; optional extension to 16 weeks
Timing
Any consistent time; rotate injection sites
Route
Subcutaneous
Cycle
8-12 weeks on, equal time off

Inject once daily subcutaneously using the 3.0 mL dilution to keep measurements practical on a U-100 insulin syringe. Lower starting doses land near 9 units, so smaller-capacity syringes may improve readability. Dosing is extrapolated from Semax-class and preclinical Adamax data; human validation remains limited.

Dose progression

Weeks 1-2
300 mcg (0.3 mg) · 9 units (0.09 mL)
Weeks 3-4
500 mcg (0.5 mg) · 15 units (0.15 mL)
Weeks 5-6
750 mcg (0.75 mg) · 23 units (0.23 mL)
Weeks 7-8+
1,000 mcg (1.0 mg) · 30 units (0.30 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How Adamax works.

Adamax is described as an adamantane-modified Semax analog intended to increase peptide stability and improve central nervous system delivery. Mechanism-based discussion focuses on BDNF signaling, TrkB sensitivity, monoaminergic modulation, and cAMP/CREB pathway activity.

The source material cites preclinical evidence suggesting stronger cognitive and endurance effects than standard Semax, but peptide-specific human clinical data remain sparse. That makes the mechanistic rationale more developed than the direct human outcome evidence.

Science · 02

Effects

Observations from clinical or preclinical literature.

May support learning, memory consolidation, and mental clarity based on preclinical Semax-class literature
Mechanism-based rationale supports neuroprotection and neuronal stress resistance
May support mood resilience through dopaminergic and serotonergic modulation
Potentially improved peptide stability and blood-brain barrier penetration versus standard Semax
Mild injection-site reactions such as redness, itching, or discomfort may occur
Long-term human safety data for Adamax specifically remain limited
Science · 03

Caution

Not recommended during pregnancy or breastfeeding because safety data is insufficient
Use caution with medications that affect dopamine or serotonin pathways
Individuals with seizure disorders should consult a qualified neurologic clinician before use because the protocol is tied to neurotrophic signaling
Consult a qualified healthcare provider before use if you have chronic medical conditions or take CNS-active medications

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

Omega-3 fatty acids
Support neuronal membrane integrity and complement neuroplasticity-focused protocols.
B vitamins
Support neurotransmitter synthesis and methylation pathways relevant to cognitive function.
Magnesium
Supports synaptic function and enzymatic processes involved in neuronal recovery.
Vitamin D
Associated with neuroprotective signaling and broader CNS health.
Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Support cognitive recovery with a nutrient-dense diet rich in omega-3 fats, antioxidants, and B vitamins
Use regular aerobic and resistance exercise to reinforce endogenous BDNF signaling
Prioritize 7-9 hours of sleep because neuroplasticity and cognitive recovery are sleep-dependent
Manage stress and limit excessive alcohol intake because both can counteract cognitive-support goals
Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

  1. Cognitive function - track focus, memory, and mental clarity over time
  2. Mood and stress resilience - monitor anxiety, motivation, and emotional regulation trends
  3. Sleep quality - poor sleep can blunt perceived nootropic benefit
  4. Injection-site reactions - note redness, swelling, or discomfort to guide site rotation
Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

CBC (Complete Blood Count)
General health monitoring and baseline screening.
CMP (Comprehensive Metabolic Panel)
Assess liver and kidney function during peptide use.
Thyroid panel
Useful when broader fatigue or cognitive complaints may overlap with thyroid status.
Vitamin D and B12
Check key cofactor sufficiency for neurologic support.
Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length
Vial size
Bac. water
Syringe
Vials
0 × 10 mg each…
Syringes
0
Bac. water
0 mL
Swabs
02 per syringe
Calculators · 02

Dose Calculator

Dose Calculator

Vial
Bac. water
Syringe
Dose
Concentration
0mcg/mL
Volume per dose
0mL
…
Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

  1. Allow vial to reach room temperature for 15–20 minutes before reconstitution.
  2. Draw the chosen bacteriostatic water volume with a sterile syringe.
  3. Inject slowly down vial wall; avoid foaming.
  4. Gently swirl/roll until dissolved (do not shake).
  5. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
  6. Use within 30 days; discard any unused solution after 30 days.
Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry
Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue
Do not aspirate for subcutaneous injections; inject slowly and steadily
Rotate sites systematically across the abdomen, thighs, and upper arms
Discard used syringes immediately in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized
Store at room temp in dry, dark conditions; minimize moisture exposure.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.
Reference · 01

Notes

Use a new sterile insulin syringe for each injection and dispose of it safely
Lower starting doses may be easier to read on 30-unit or 50-unit syringes
Document dose, timing, and subjective cognitive effects for consistency
Human data for Adamax remain limited and are less developed than Semax data
PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.
Reference · 02

References

  1. PMC
    Semax-class neuroprotective and nootropic literature overview.
    https://pmc.ncbi.nlm.nih.gov/
  2. Neuroscience Letters
    ACTH fragment analog and adamantane-modification research relevant to BBB penetration.
    https://pubmed.ncbi.nlm.nih.gov/
  3. Journal of Neurochemistry
    BDNF and TrkB signaling in hippocampal neuroplasticity.
    https://pubmed.ncbi.nlm.nih.gov/
  4. Frontiers in Neuroscience
    Semax-class peptide mechanisms involving monoaminergic modulation.
    https://www.frontiersin.org/journals/neuroscience
  5. CDC
    Subcutaneous injection route guidance.
    https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf
  6. WHO (NCBI Bookshelf)
    Injection-safety guidance for subcutaneous administration.
    https://www.ncbi.nlm.nih.gov/books/NBK390474/
On this page